CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
21 hedge funds and large institutions have $14.6M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
80% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 10
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.25M | |
| 2 | +$268K | |
| 3 | +$58K | |
| 4 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$7.77K |
| 5 |
JWA
JFS Wealth Advisors
Hermitage,
Pennsylvania
|
+$5K |
Top Sellers
| 1 | -$897K | |
| 2 | -$172K | |
| 3 | -$87.3K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$84.7K |
| 5 |
Citigroup
New York
|
-$45.6K |